Year
2025
Summary
This research investigates the safety of targeted synthetic DMARDs during pregnancy in people with autoimmune joint diseases. Using 20 years of population-level health data, it identifies increased risk of low birth weight associated with prenatal exposure. The findings aim to inform clinical guidance and empower patients to make safer, evidence-based decisions about pregnancy.